PWEAX
Price
$20.12
Change
-$0.39 (-1.90%)
Updated
Jun 10 closing price
Net Assets
570.92M
RNWAX
Price
$97.13
Change
-$2.23 (-2.24%)
Updated
Jun 10 closing price
Net Assets
90.88B
Interact to see
Advertisement

PWEAX vs RNWAX

Header iconPWEAX vs RNWAX Comparison
Open Charts PWEAX vs RNWAXBanner chart's image
PWEAX vs RNWAX Comparison Chart in %
View a ticker or compare two or three
VS
PWEAX vs. RNWAX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PWEAX is a Hold and RNWAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 90.9B vs. PWEAX (571M). PWEAX pays higher dividends than RNWAX: PWEAX (1.35) vs RNWAX (0.49). PWEAX was incepted earlier than RNWAX: PWEAX (26 years) vs RNWAX (24 years). RNWAX (1.66) and PWEAX (1.61) have similar cost to investors . PWEAX is a more actively managed with annual turnover of: 70.00 vs. RNWAX (46.00). RNWAX has a lower initial minimum investment than PWEAX: RNWAX (250) vs PWEAX (1000). PWEAX annual gain was more profitable for investors over the last year : 42.53 vs. RNWAX (18.14). PWEAX return over 5 years is better than : 21.71 vs. RNWAX (6.40).
PWEAXRNWAXPWEAX / RNWAX
Total Expense Ratio1.451.6687%
Annual Report Gross Expense Ratio1.611.6697%
Fund Existence26 years24 years-
Gain YTD21.8669.430232%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets571M90.9B1%
Annual Yield % from dividends1.350.49278%
Returns for 1 year42.5318.14234%
Returns for 3 years72.2941.80173%
Returns for 5 years21.716.40339%
Returns for 10 years116.8399.72117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLW16.550.25
+1.53%
Clearwater Paper Corp
PEBO36.060.45
+1.26%
Peoples Bancorp
BMO164.39-0.83
-0.50%
Bank of Montreal
TFX132.15-3.60
-2.65%
Teleflex
NRSN0.73-0.03
-3.78%
NeuroSense Therapeutics Ltd